Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_02649 |
| Species: | Mus musculus |
| Position : | chr7:19411994-19412088 |
| Year: | 2011 |
| Title: | Differentiation and fiber type-specific activity of a muscle creatine kinase intronic enhancer. |
| Genome Build: | mm10 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| PMID: | 21797989 |
| Tissue: | skeletal muscle tissue |
| Tissue Ontology ID: | UBERON:0001134 |
| Cell Source: | MM14 |
| CVCL ID: | CVCL_L439 |
| Cell Type: | myoblast |
| Cell Ontology ID: | CL:0000056 |
| Experiment Type: | Enhancer activity assay; TF binding assay; Functional perturbation assay; Chromatin-state profiling |
| High Throughput Method: | ChIP-seq |
| Low Throughput Method: | CAT Reporter Assay; ChIP-qPCR; Site-directed mutagenesis; EMSA; ChIP |
| Target gene : | Ckm |
| TF name : | Myog |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| Myog | CDO in myogenesis | reactome | 29 |
| Myog | ID | netpath | 38 |
| Myog | Regulation of nuclear beta catenin signaling and target gene transcription | pid | 80 |
| Myog | Hs_Hypertrophy_Model_WP516_88898 | wikipathways | 17 |
| Myog | Hs_Wnt_Signaling_Pathway_WP428_90292 | wikipathways | 7 |
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_02648 | chr7:19411994-19412088 | skeletal muscle tissue | myoblast | NA |
| E_02667 | chr7:19411995-19412089 | skeletal muscle tissue | skeletal muscle myoblast/myocyte | NA |
| E_02668 | chr7:19411995-19412089 | skeletal muscle tissue | skeletal muscle myoblast/myocyte | NA |
| E_02669 | chr7:19411995-19412089 | skeletal muscle tissue | skeletal muscle myoblast/myocyte | NA |